Natural ingredients manufacturer Sabinsa Corporation and sister company Sami Labs have been awarded seven new patents.
Natural ingredients manufacturer Sabinsa Corporation and its sister company Sami Labs have been awarded seven new patents, bringing their global patent portfolio to 87. They include PteroWhite which was awarded the DPR Korea Patent 1011504. The patent discusses the ability of pterostilbene to modulate melanogenesis and skin hyper-pigmentation.
In addition, US patent US8383594 for OLEPENT covers ‘Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals’, specifically a unique pentapeptide linked chemically to plant ￼derived Oleanolic acid and associated cosmetic compositions. Because of its potential for regenerating the dermal matrix, Sabinsa said OLEPENT is particularly relevant to anti-ageing ingredients.
European Patent EP1791423 for BOSWELLIN discusses the unique therapeutic potential of boswellic acids in combination with selenium amino acids to effectively manage inflammatory conditions of immunological origin like psoriasis, while New Zealand issued patent NZ598630 for the proprietary Saberry and Cococin synergistic formulation and its protective effect on the dermal papilla cells. This invention already holds US Patent US8247003.